Mismatch Between Preoperative MRI Findings and Postoperative Histological Results in the Treatment of Tenosynovial Giant Cell Tumor
Anticancer Research · 2025
DOI: 10.21873/anticanres.17496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Johannes Neugebauer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedics and Traumatology, University Hospital Krems, Krems, Austria; johannes.neugebauer@krems.lknoe.at. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Giant Cell Tumor of Tendon Sheath. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: Tenosynovial giant cell tumor (TGCT) is a rare disease of young adults with a high number of cases going unreported. Despite an international consensus meeting of experts in June 2022, the majority of such patients repeatedly pose problems, even for experienced clinicians. This study deals with the question of how often postoperative histopathological findings are consistent with preoperative magnetic resonance imaging (MRI) findings. PATIENTS AND METHODS: In a retrospective data analysis, we investigated 137 patients at our department who had undergone synovectomy between 1991 and 2019. INCLUSION CRITERIA: positive MRI findings with evidence of T1- and T2-weighted sequence low-signal representation of the TGCT with inhomogeneous contrast medium uptake because of hemosiderin, subsequent synovectomy and complete histological report showing inconsistency with MRI findings. Because of the heterogeneity of the study group, we can only report descriptive statistics. RESULTS: The average age at diagnosis was 38 (range=9-73) years. Of 137 cases, 52 with complete data sets were included in the study. In 37 (71%) out of these 52 patients, MRI and histological findings were consistent. Of the 52 patients, 15 (29%) had a false-positive MRI finding for TGCT. CONCLUSION: Although imaging showed pathognomonic characteristics, the diagnosis of TGCT was not confirmed histopathologically in almost 29%. We therefore recommend a preoperative biopsy, especially in case of doubt, and treatment of TGCT in designated centers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Orthopaedics and Traumatology, University Hospital Krems, Krems, Austria; johannes.neugebauer@krems.lknoe.at.
- Karl Landsteiner University of Health Sciences, Krems, Austria.
- Danube University Krems, Center for Regenerative Medicine, Krems, Austria.
- Department of Trauma Surgery, BG Trauma Center Murnau, Murnau, Germany.
- Department of Orthopedics and Traumatology, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Orthopedics and Traumatology, Medical University of Graz, Graz, Austria.
Zitieren
APA
Neugebauer, J., Blum, P., Keiler, A., SÜß, M., Reinbacher, P., Neubauer, M., Leone, G., Bergovec, M., & Dammerer, D. (2025). Mismatch Between Preoperative MRI Findings and Postoperative Histological Results in the Treatment of Tenosynovial Giant Cell Tumor. Anticancer Research. https://doi.org/10.21873/anticanres.17496
Vancouver
Neugebauer J, Blum P, Keiler A, SÜß M, Reinbacher P, Neubauer M, et al. Mismatch Between Preoperative MRI Findings and Postoperative Histological Results in the Treatment of Tenosynovial Giant Cell Tumor. Anticancer Research. 2025. doi:10.21873/anticanres.17496
BibTeX
@article{Neugebauer2025,
author = {Neugebauer, Johannes and Blum, Phillip and Keiler, Alexander and SÜß, Markus and Reinbacher, Patrick and Neubauer, Markus and Leone, Gianpaolo and Bergovec, Marko and Dammerer, Dietmar},
title = {Mismatch Between Preoperative MRI Findings and Postoperative Histological Results in the Treatment of Tenosynovial Giant Cell Tumor},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17496}
}
EUVIMED